2019 MOTIVATE Course 2: History Taking, Diagnosing, and Treatment of MOH
|
1 Category 2 points with the RACGP
|
1 Core PDP point
|
All participants will be awarded a certificate of completion for self-reporting to other colleges
Duration: 30 minutes
Taking a proper history plays a big part in diagnosing headache. Physical examination and laboratory testing only rarely offer diagnostic clues. Using a simulated case study, recall the process of detailed history taking to elicit a comprehensive headache history. Also. learn the different treatment modalities of MOH.
Learning objectives:
Upon completing this course, participants will be able to:
- outline the process of detailed history taking to elicit a comprehensive headache history and be able to identify any secondary headaches that should be further investigated
- explain the different treatment modalities of MOH
- differentiate the pros and cons of outpatient versus inpatient withdrawal therapy
- create a checklist to serve as reminder of the different side effects associated with prophylactic medications.
- Associate Professor Richard Stark, Alfred Hospital, Melbourne, Victoria
- Professor Mieke Van Driel, School of Medicine, University of Queensland, Herston, Queensland
- Associate Professor Treasure McGuire, School of Pharmacy, University of Queensland, Queensland; Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland
- Dr Brett McFarlane, The Australian College of Pharmacy, Canberra, Australian Capital Territory
- Professor Deborah Turnbull, School of Psychology, University of Adelaide, South Australia
- Royal Australian College of General Practitioners:
- 1 Category Two QI&CPD points
- Activity no. 108889
- Australian College of Rural and Remote Medicine:
- 1 Core PDP point
- Activity no. 10378
- Pharmacists and nurses are invited to access this continuing professional development activity. At the end, a certificate may be downloaded as proof of completion.
Dr Lara Mihaljevic
General Practitioner
Drummoyne Medical Centre, Victoria Road, Drummoyne, NSW
- Faculty
- Associate Professor Richard Stark: Co-authored a clinical paper sponsored by Pfizer on the safety of eletriptan. Between 2012 and 2014 received consulting and lecture fees from Allergan and lecture fees from MSD on chronic migraine
- Professor Mieke Van Driel: No conflict of interest
- Associate Professor Treasure McGuire: No conflict of interest
- Dr Brett McFarlane: No conflict of interest
- Professor Deborah Turnbull: Received research grants and co-authored papers on hypertension sponsored by pharmaceutical companies, including Pfizer Pty. Ltd., between 1999 and 2006
- GP reviewer
- Dr Lara Mihaljevic: No conflict of interest
- Non-faculty: employees of In Vivo Academy involved in producing the content of this course, Yulyana, Tina Garcia, Monica Kurniawan and Lisa Sullivan, declare no conflict of interest.
